Toshiyama, Reishi
Konno, Masamitsu
Eguchi, Hidetoshi
Takemoto, Hiroyasu
Noda, Takehiro
Asai, Ayumu
Koseki, Jun
Haraguchi, Naotsugu
Ueda, Yuji
Matsushita, Katsunori
Asukai, Kei
Ohashi, Tomofumi
Iwagami, Yoshifumi
Yamada, Daisaku
Sakai, Daisuke
Asaoka, Tadafumi
Kudo, Toshihiro
Kawamoto, Koichi
Gotoh, Kunihito
Kobayashi, Shogo
Satoh, Taroh
Doki, Yuichiro
Nishiyama, Nobuhiro
Mori, Masaki
Ishii, Hideshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (17H04282, 17K19698, 16K15615, 15H05791)
Japan Agency for Medical Research and Development (270915)
Article History
Received: 25 January 2018
Revised: 13 May 2018
Accepted: 8 June 2018
First Online: 8 August 2018
Compliance with ethical standards
:
: YD, MM, HI received Institutional endowments were received from Taiho Pharmaceutical Co., Ltd., Unitech Co., Ltd. (Chiba, Japan), IDEA Consultants, Inc. (Tokyo, Japan), and Kinshu-kai Medical Corporation (Osaka, Japan); DS, TK, TS, YD, MM received Chugai Co., Ltd., Yakult Honsha Co., Ltd., and Merck & Co., Ltd (YD, MM, TS). The remaining authors declare that they have no conflict of interest.